Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.

Fournier, Christina N

Fournier, Christina N.

Affiliation

Fournier CN; Department of Neurology, Emory University, Atlanta, GA, USA. cfourni@emory.edu.

Neurotherapeutics ; 19(4): 1180-1192, 2022 07.

Article in En | MEDLINE | ID: mdl-35819713

Subject(s)

Amyotrophic Lateral Sclerosis; Humans; Amyotrophic Lateral Sclerosis/drug therapy; Reproducibility of Results; Clinical Trials as Topic; Biomarkers; Disease Progression

Key words

Amyotrophic lateral sclerosis (ALS); Biomarkers; Clinical trials; Outcome measures; Prediction models

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Neurotherapeutics Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google